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The present study evaluated the role of N-methyl-D-aspartate
receptors (NMDARs) expressed in the dorsal root ganglia (DRG)
in the inflammatory sensitization of peripheral nociceptor termi-
nals to mechanical stimulation. Injection of NMDA into the fifth
lumbar (L5)-DRG induced hyperalgesia in the rat hind paw with a
profile similar to that of intraplantar injection of prostaglandin
E2 (PGE2), which was significantly attenuated by injection of
the NMDAR antagonist D(-)-2-amino-5-phosphonopentanoic
acid (D-AP-5) in the L5-DRG. Moreover, blockade of DRG AMPA
receptors by the antagonist 6,7-dinitroquinoxaline-2,3-dione
had no effect in the PGE2-induced hyperalgesia in thepaw, show-
ing specific involvement of NMDARs in this modulatory effect and
suggesting that activation of NMDAR in the DRG plays an impor-
tant role in the peripheral inflammatory hyperalgesia. In following
experiments we observed attenuation of PGE2-induced hyperalgesia
in the paw by the knockdown of NMDAR subunits NR1, NR2B,
NR2D, and NR3A with antisense-oligodeoxynucleotide treatment
in the DRG. Also, in vitro experiments showed that the NMDA-
induced sensitization of cultured DRG neurons depends on satel-
lite cell activation and on those same NMDAR subunits, suggesting
their importance for the PGE2-induced hyperalgesia. In addition,
fluorescent calcium imaging experiments in cultures of DRG cells
showed induction of calcium transients by glutamate or NMDA
only in satellite cells, but not in neurons. Together, the present
results suggest that the mechanical inflammatory nociceptor sen-
sitization is dependent on glutamate release at the DRG and sub-
sequent NMDAR activation in satellite glial cells, supporting the
idea that the peripheral hyperalgesia is an event modulated by
a glutamatergic system in the DRG.
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The involvement of excitatory amino acids in the transmissionof the nociceptive information from the primary afferent
neurons to the spinal cord is, at present, supported by an
immense number of studies (1–3). In fact, a role of the amino
acid glutamate (GLU) as a synaptic mediator has been demon-
strated by electrophysiological experiments that showed its
release by stimulation and consequent increase in the probability
that the target cell will fire an action potential (3, 4). In addition,
glutamatergic receptors, especially the N-methyl-D-aspartate
receptor (NMDAR), detected throughout the entire nervous sys-
tem (5, 6), have been associated with the development and main-
tenance of spinal cord neuron sensitization (7, 8). Stimulation of
spinal neurons by GLU through NMDARs was also associated to
inflammatory processes (3, 9). For instance, sensitization of spinal
nerves has been frequently related to the wind-up phenomenon, an
increase in the electrical activity of spinal cord neurons and pain
sensation independent of primary nociceptor input (10).
The detection of glutamatergic receptors in the presynaptic
membrane of afferent fibers associated with nociception and
hyperalgesia raised the hypothesis that GLU released into the
synaptic cleft could also activate receptors expressed in the central
terminals of primary afferent neurons (11, 12). Moreover, the
possibility that GLU is involved in nociceptor sensitization was
strengthened by reports of the expression of NMDARs in noci-
ceptors (13) and their role in acute and persistent inflammatory
mechanical hyperalgesia in the rat paw (13, 14). In addition, the
glutamatergic role in the sensitization of the primary sensory noci-
ceptive neuron is indirectly supported by GLU-induced neuronal
depolarization (4).
Previous studies from our group have stressed the importance
of GLU in the sensitization of the primary sensory neuron
with the introduction of the concept of glutamate retro-
grade sensitization (15–17), focusing especially on the role
of NMDARs in this process. In those studies, we demonstrated
that the intrathecal (i.t.) injection of GLU, NMDA, or AMPA
(another ionotropic glutamatergic receptor agonist) induced
mechanical hyperalgesia in the rat hind paws in a dose-dependent
manner. However, because the intraplantar (i.pl.) injection of either
morphine or the nitric oxide donor S-nitroso-N-acetylpenicillamine
(SNAP) [previously demonstrated, along with dipyrone and diclo-
fenac, to cause local analgesia (18–20)], ipsilaterally antagonized
hyperalgesia induced by i.t. NMDA, but not AMPA, we have
proposed that the primary nociceptive neuron is the main site of
action of the i.t.-injected NMDA. Moreover, i.t. administration of
the NMDA antagonists D(-)-2-amino-5-phosphonopentanoic acid
(D-AP-5) or MK801, but not of the AMPA receptor antagonist
6-cyano-7-nitroquinoxaline-2,3-dione, inhibited the hyperalgesia
induced by i.pl. injection of prostaglandin E2 (PGE2) or carra-
geenan. These results suggested that the maintenance of noci-
ceptor sensitization by inflammatory stimuli depends on a
continuous spinal release of GLU that acts on presynaptic NMDA-
type receptors (15, 17). Furthermore, the proposal of a GLU-
dependent retrograde sensitization of the primary sensory neuron
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was supported by the additional demonstration that the selective
knockdown of NaV1.8 (SNS/PN3) sodium channels [described to
be expressed only in nociceptors and associated with inflammatory
sensitization (21)] in the dorsal root ganglion (DRG) by i.t. treat-
ment with antisense oligodeoxynucleotides (AS-ODNs) abolished
the mechanical hyperalgesia induced by i.t. administration of
NMDA (16).
Those data, and the fact that the cerebrospinal fluid, in addition
to being in contact with the spinal cord, also bathes part of the
DRG (22, 23), led to the suggestion that i.t.-injected drugs could
directly reach the DRGs of the primary sensory neurons (24).
Thus, considering the methodology used to demonstrate the ret-
rograde sensitization (15, 17), we raised the possibility that
i.t-administered drugs actually targeted receptors located at the
DRG and not at the presynaptic membrane in those experiments.
In the present study, we investigated whether NMDARs
expressed at the DRG participate in the modulation of the
excitability of primary afferent neurons during inflammatory
nociceptive sensitization. We tested whether the intraganglionar
(i.gl.) injection of NMDA, into the fifth lumbar (L5)-DRG, had
a direct hyperalgesic effect and whether i.gl. injection of the
NMDAR antagonist D-AP-5 could inhibit the nociceptor sensi-
tization induced by i.t. NMDA or i.pl. PGE2 administration. The
specificity of ganglionar and spinal GLU receptors was tested by
comparing the effects of selective antagonists for NMDA and
AMPA receptors. We also evaluated the functional expression
of NMDARs in DRG primary cultures in experiments using a
fluorescent calcium indicator. Finally, we investigated the in-
dividual relevance of each subunit of NMDAR for the development
of i.pl. PGE2-induced hyperalgesia and in the activation of
NMDARs in DRG cultures.
Results and Discussion
Mechanical Hyperalgesia Induced by i.t. or i.gl. Injection of NMDA.
Currently, drugs administered via the i.t. route are assumed to
act mainly in the spinal cord (25, 26). However, the cerebrospinal
fluid also bathes the proximal processes of the primary sensory
neurons, as well as a portion of the DRG (22, 23, 27). Consid-
ering that (i) the direct effect of AS-ODN, which decreases the
mRNA expression of different molecules in the DRG of
peripheral neurons following i.t. injections, is well documented
(16, 28), and (ii) behavioral tests have shown that i.t. injection of
PGE2 or NMDA exerts a predominantly hyperalgesic action on
primary sensory neurons (15, 17), we compared the magnitude
and time course of the mechanical hyperalgesia induced by
NMDA administered by two different routes—either i.t. or i.gl.
Of note, it is important to highlight that, for the i.gl. admin-
istration of the compounds in the present study, small volumes
were used, allowing their injection to be restricted to the gan-
glia (24).
Fig. 1A shows the hyperalgesic effect of three doses of NMDA
(25, 80, and 240 ng) administered by the i.t. (Fig. 1 A, Left) or
i.gl. (Fig. 1 A, Right) route. The lack of significant difference in
the magnitude of the hyperalgesia induced by the injection of
80 and 240 ng of NMDA by the i.t. route may indicate that
i.t.-injected drugs reach several DRGs. Thus, a small i.t. dose
produces a stronger effect than when it is injected into a single
ganglion. Also, this apparent contradiction may reflect the dif-
fusion of the i.t. injection of NMDA through the spinal fluid,
affecting other ganglia involved in the mechanical hyperalgesia
in the hind paw, in addition to the L5-DRG. Based on these
results, we selected the doses of 80 and 240 ng of NMDA for the
i.t and i.gl. injections, respectively, in the other experiments of
this study. These doses were also used to compare the time
course of the NMDA-induced hyperalgesia with the hyperalgesia
induced by i.pl. injection of PGE2, shown in Fig. 1B. We
observed that the mechanical hyperalgesia induced by the i.pl.
injection of PGE2 and by NMDA, injected by the i.t. or i.gl.
route, displayed a very similar profile, with the peak of sensiti-
zation at the third hour after administration. This time point was
thus chosen for the analysis of further experiments.
Mechanical Hyperalgesia in the Hind Paw Induced by i.gl. Injection of
NMDA Is Not Dependent on Release of PGE2. Because we observed
similarities between the hyperalgesia induced by NMDA and
PGE2, we considered the possibility that the effect of NMDA
could result from release of endogenous prostanoids. In this
case, its effect would be indirect and prevented by the treatment
with the nonselective ciclooxygenase inhibitor indomethacin
(29). Fig. S1 shows that neither the i.t. (100 μg per 10 μL) nor
the systemic [intraperitoneal (i.p.); 5 mg/kg] administration of
indomethacin affected the hyperalgesia induced by the i.gl.
administration of NMDA, indicating a direct effect of NMDA
on DRG cells, not dependent on ciclooxygenase activation and
further prostaglandin release.
Blockade of NMDARs in the DRG Attenuates the Mechanical
Hyperalgesia Induced by i.t. NMDA or i.pl. PGE2. Fig. 2 shows
that i.gl. administration of 3 or 9 μg of the selective NMDAR
antagonist D-AP-5 equally attenuated the mechanical hyper-
algesia induced by i.pl. PGE2 (Fig. 2A) or i.t. NMDA (Fig.
2B) only in the ipsilateral paw, with no effect on the contra-
lateral paw.
We also evaluated the effect of the NMDAR antagonist on the
time course of the i.pl. PGE2-induced mechanical hyperalgesia.
The results shown in Fig. S2 strongly suggest that the hyper-
algesia induced by injection of PGE2 in the hind paw is
dependent on the activation of NMDARs. When D-AP-5 was
Fig. 1. Mechanical hyperalgesia induced by i.t. or i.gl. injection of NMDA.
(A) NMDA was injected by the i.t. (Left) or i.gl. (Right) route, and the me-
chanical threshold was evaluated 3 h later by the electronic von Frey test.
Results represent the means ± SEM of five paws per group. ***P < 0.001
compared with the saline and the 25-ng groups (Left), and to the saline and
the 25- and 80-ng groups (Right) (one-way ANOVA followed by Bonferroni
posttest). (B) Time course of the mechanical hyperalgesia induced by i.pl.
injection of PGE2 (■) and i.t. (♢) or i.gl. (△) administration of NMDA at the
indicated doses, evaluated by the electronic von Frey test. Results represent
the means ± SEM of five paws per group [no significant difference was found
between the ■, ♢, and△ groups; P < 0.05 when those groups are compared
with the saline group (one-way ANOVA followed by Bonferroni posttest)].
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injected by the i.t. route (Fig. S2A), a short-lasting but significant
inhibition of the PGE2 hyperalgesia was observed, but this effect
was no longer present by the third-hour time point, when the
mechanical sensitization reached values similar to those detected
in the control group (PGE2 plus saline). This result contrasts
with the marked inhibition observed in the group treated with
i.gl. injection of D-AP-5 (Fig. S2B), in which the mechanical
hyperalgesia induced by PGE2 remained attenuated until the
third hour after PGE2, then increasing until it reached values
comparable with those observed in the control group (PGE2 plus
saline). The groups that received only D-AP-5 injected by either
route did not exhibit significant changes in mechanical threshold.
This difference in the effect of D-AP-5 on the PGE2-induced
hyperalgesia when injected by different routes may reflect the
possibility that drugs injected i.t. diffuse promptly into the cer-
ebrospinal fluid. However, in the DRG, the diffusion rate might
be reduced because the drug will be confined in a smaller
compartment, slowing its diffusion rate.
Because D-AP-5 caused a strong inhibition of the hyperalgesia
in the ipsilateral, with no effect on the contralateral, paw when
administered into the DRG and in both paws when injected in
the spinal cord, it is safe to infer that drugs administered into the
DRG have a major effect at this site. In addition, these results
suggest that the modulation of the hyperalgesia induced by
peripheral injection of PGE2 is dependent on the activation of
NMDARs present at the DRG.
AMPA Receptors Involved in the i.pl. PGE2-Induced Hyperalgesia Are
Not Located at the DRG. Fig. S3A shows that the administration of
AMPA by the i.t., but not by the i.gl., route induced mechanical
hyperalgesia. This hyperalgesic effect of AMPA was, as depicted
in Fig. S3 B and C, significantly inhibited by i.t. (Fig. S3B), but
not by i.gl. (Fig. S3C), injection of the AMPA receptor antago-
nist 6,7-dinitroquinoxaline-2,3-dione (DNQX; 40 ng). Moreover,
the i.pl. injection of PGE2 (Fig. S3D) induced hyperalgesia that
was significantly attenuated by i.t., but not i.gl., injection of
DNQX. Together, these results indicate that the activation of
AMPA receptors located in the spinal cord is necessary for the
hyperalgesia induced by i.pl. PGE2.
All three ionotropic glutamatergic receptors—i.e., AMPA,
kainate and NMDA—have been shown to be expressed in rat
DRG neurons (30, 31). However, the ganglionar AMPA recep-
tors, in contrast to those expressed postsynaptically in the dorsal
horn, do not appear to be involved in the sensitization of the
primary sensory neuron, as suggested herein and in our previous
study (15). Conversely, it has been suggested that presynaptic
AMPA receptors on the central terminals of primary afferent
neurons play a role in the modulation of nociceptors involved
primarily in neuropathic pain (31). Thus, based on the present
model of nociceptor sensitization, AMPA receptors are mainly
involved in the sensitization of second-order neurons in the
dorsal horn of the spinal cord.
Activation of NMDARs in Primary DRG Cultures. Functional responses
of NMDARs were observed through confocal microscopy as cal-
cium transients in DRG cultures loaded with the calcium-sensitive
fluorescent probe Fluo-3 AM (Figs. 3 and 4 and Fig. S4).
Primary cultures of DRG contain mainly primary sensory
neurons and satellite glial cells. Upon dissociation of DRG cells,
satellite cells remained attached to neurons. After 24 h in cul-
ture, those cells still surrounded neurons and could be clearly
visualized in the fluorescent confocal images (Fig. 3 A and B and
Fig. S4 A–C). At this step of the protocol, calcium experiments
with neurons were difficult to perform because most of the cal-
cium sensor (Fluo-3 AM) was localized in the satellite cells and
did not reach neurons. However, as shown in Fig. S4 A–C, after
36 h in culture, the satellite cells migrated to the bottom of the
dish and proliferated, assuming a fibroblast-like shape.
As shown in Fig. 3, the administration of GLU (500 μM)—in
the presence of glycine (10 μM) in buffer solution without Mg2+—
to the DRG cultures after 24 h, induced calcium transients only in
satellite cells, even though nociceptive neurons were present and
functional, as confirmed by their response to administration of the
transient receptor potential vanilloid 1 (TRPV1) agonist cap-
saicin. Moreover, the effect of GLU was significantly attenuated
by prior administration of the NMDAR antagonist D-AP-5 (200
μM; Fig. 3D). Similarly, the administration of NMDA (250 μM;
Fig. 2. Effect of the i.gl. injection of D-AP-5 on the mechanical hyperalgesia
induced by NMDA or PGE2. Mechanical hyperalgesia in the hind paw was
evaluated 3 h after the injection of PGE2 (100 ng, i.pl.; A) or NMDA (80 ng,
i.t.; B), in the presence of 1, 3, or 9 μg of the NMDAR antagonist D-AP-5,
injected into the DRG (i.gl.) 60 min before the measurements. In both cases,
the doses of 3 and 9 μg of D-AP-5 significantly attenuated the hyperalgesia.
*P < 0.05 compared with the saline groups; results represent the means ±
SEM of five paws per group (ANOVA followed by Bonferroni posttest).
Fig. 3. GLU-induced calcium transients in glial satellite cells. A and B show
confocal images of primary DRG cells cultured for 24 h, in which satellite cells
are found attached to the primary sensory neuron soma. (A) Basal fluo-
rescence of DRG cells. (B) Fluorescence changes immediately after GLU (500
μM) administration. (C) Representative curves of the fluorescence variation
over time induced by GLU (500 μM) in the presence or absence of D-AP-5 (200
μM). Each curve represents the response of one satellite cell. (D) Maximum
fluorescence increase induced by GLU (500 μM) alone or in the presence of
D-AP-5 (200 μM). Results represent the means ± SEM of 16–26 cells in three
different experiments. Experiments were performed in the presence of glycine
(10 μM) in Mg2+-free buffer. *P < 0.05 compared with the effect of GLU
without D-AP-5 (ANOVA followed by Bonferroni posttest).
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Fig. 4) under the same conditions described for GLU also in-
duced calcium transients in satellite cells, but not in neurons.
The GLU- or NMDA-induced calcium transients in neurons
were very rare, although functional nociceptive neurons were
present, as confirmed by the treatment with capsaicin (Fig. 4C).
In fact, we did observe neuronal responses to capsaicin in a 24-h
culture; however, such responses were more easily observed in
36-h cultures because of the easier loading of neurons with the
fluorescent indicator in this case. Therefore, our experiments
indicate that the release of GLU in the DRG activates
NMDARs on the satellite cells and suggest a glutamatergic role
at the DRG as a communicating system between neurons and
these glial cells. Because there are no synapses in the DRG, this
cross-talk between neurons and satellite cells may well have
physiological relevance because GLU cannot diffuse from one
neuron to another. Also, this possibility is strengthened by the
expression of GLU transporters and glutamine synthetase in
satellite cells, as reported (32, 33).
In resting state, NMDARs have been described to be blocked
by a voltage-sensitive “plug” of Mg2+ (34). To allow the entrance
of calcium through the activated receptor pore, the Mg2+ plug
must be removed by a previous depolarizing stimulus (34–36).
However, we found that the NMDARs expressed in satellite cells
are not sensitive to the Mg2+ blockade (Fig. 4D), as observed in
other glial cells such as astrocytes (37, 38). Thus, these receptors
in the satellite cells can be promptly activated regardless of the
negative membrane resting potential of these cells.
Release of GLU in the DRG as a regulatory mechanism of the
nociceptive information has also been suggested in a recent study
from Kung et al. (39), who observed an increase in GLU in cell
bodies and satellite cells after depolarization and consequent
activation of AMPA, kainate, and metabotropic receptors, in
addition to NMDARs. However, those results contrast with ours,
because we have observed activation of NMDARs only in sat-
ellite cells. Differences in experimental protocols used in these
studies could explain such discrepancies. While those authors
used the calcium-sensitive fluorescent dye Fura-2 AM, which
requires excitation at two wavelengths, and a CCD camera,
which provides limited resolution of images to register neuronal
activation in cultures, we used Fluo-3 AM, which requires
excitation at only one wavelength, and confocal microscopy. In
this regard, in our experience, without the use of confocal
microscopy, it is very difficult to differentiate the effects of
stimulation from satellite cells and neurons in 24-h cultures.
Indeed, at this time point, satellite cells usually cover neuronal
cell bodies, and in this configuration, most of the fluorescent
indicator is loaded in these cells, not reaching neurons, as clearly
shown in Fig. 3B. Importantly, it is also of note that our results
show a role of NMDA, but not AMPA, receptors in the DRG in
the development of inflammatory hyperalgesia, whereas those
authors have shown the involvement of other types of GLU
receptors in a model of neuropathic pain [i.e., chronic con-
striction injury (40, 41)]. These findings suggest the involvement
of different types of GLU receptors in the DRG during in-
flammatory and neuropathic hyperalgesia. Nevertheless,
both reports stress the importance of the glutamatergic recep-
tors in DRG satellite cells in the regulation of the afferent
nociceptive information as a new concept idea in terms of neu-
ronal physiology.
Role of NMDARs Subtypes in the Mechanical Hyperalgesia Induced by
PGE2. Three main families of NMDAR subunits have been
identified: NR1, NR2 (NR2A, -2B, -2C, and -2D), and NR3
(NR3A and NR3B) (42, 43). Recent studies have provided an
understanding on how the expression of individual subunits
may alter the mechanisms underlying the signaling properties
of NMDARs (44, 45). However, only a few brief studies address
the functional properties of NMDARs in primary sensory
neurons (4, 46).
Fig. 4. NMDA-induced calcium transients in satellite cells in the presence or
absence of Mg2+. A–C show confocal images of Fluo-3 AM-loaded primary
DRG cells cultured for 36 h, in which the satellite cells are observed to pro-
liferate and migrate to the bottom of the dish. (A) Basal fluorescence of DRG
cells. (B) Increase in fluorescence observed immediately after NMDA (250
μM) administration. (C) Increase in fluorescence observed in neurons after
the administration of capsaicin (1 μM), used to verify the viability of noci-
ceptive neurons. (D) Maximal fluorescence increase after NMDA (250 μM or
1 mM) administration in the presence or absence of Mg2+ (0.9 mM) in buffer.
Results represent the means ± SEM of 17–22 cells in three different experi-
ments. Statistical analysis, performed by using ANOVA followed by Bonferroni
posttest, failed to detect significant differences between the groups.
Fig. 5. Effect of the selective knockdown of NMDAR subunits in the DRG on
the mechanical hyperalgesia induced by i.pl. administration of PGE2. AS-
ODNs specific for each NMDAR subunit were administered, in different
groups of rats, for five consecutive days into the L5-DRG (20 μg/5 μL). On the
fifth day, after the injection of the ODNs, PGE2 (100 ng) was administered s.c.
in the plantar surface of the rat hind paw, and, 3 h later, the mechanical
threshold was evaluated by the electronic von Frey test. Significant attenu-
ation of the PGE2-induced hyperalgesia was observed in the groups treated
with AS-ODN (filled bars) for the subunits NR1, NR2B, NR2D, and NR3A.
Results represent the means ± SEM of five paws per group. *P < 0.001
compared with respective missense-ODN groups (open bars) (one-way
ANOVA followed by Bonferroni posttest).
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In the last series of experiments, the contribution of each
NMDAR subunit in the mechanical hyperalgesia induced by i.pl.
injection of PGE2 (100 ng; Fig. 5) was investigated. The selective
knockdown of each subunit was produced by the i.gl. treatment
with AS-ODN (20 μg in 5 μL) for five consecutive days. On the fifth
day, PGE2 was injected in the hind paw, and, 3 h later, the
mechanical hyperalgesia was evaluated. Importantly, none of the
AS-ODNs caused change in the mechanical threshold in the hind
paw per se. Fig. 5 shows that the mechanical hyperalgesia
induced by PGE2 was significantly attenuated by the knockdown
of the subunits NR1, NR2B, NR2D, or NR3A, whereas no
changes were observed following the knockdown of NR2A,
NR2C, or NR3B. Of note, this attenuation of hyperalgesia was
stronger in the NR1- and NR2B-depleted animals than in the
NR2D- and NR3A-depleted animals, although the depletion of
all of these subunits significantly attenuated the PGE2-induced
hyperalgesia compared with the missense-ODN–treated groups.
To confirm the effect of the AS-ODN on the expression of the
different NMDAR subunits in the DRG, after the behavioral
tests, the L5-DRGs of the animals were surgically harvested for
mRNA analysis by real-time PCR. We found that, in all tested
groups, there was a significant decrease in the mRNA expression
of the respective NMDAR subunits (Fig. S5).
We also evaluated in vitro the role of the subtypes of
NMDARs that were shown to be relevant for the hyperalgesic
effect of PGE2 in the hind paw, in the functional responses to
NMDA administration observed in satellite cells. Primary cul-
tures were prepared from rats treated, for four consecutive days,
with AS-ODN against the mRNAs of the subunits NR1, NR2B,
NR2D, or NR3A. As shown in Fig. S6, the AS-ODN treatment
resulted in a reduction of calcium transients induced by NMDA,
in a similar way to the attenuation of PGE2 hyperalgesia
observed in vivo. The inhibition of expression of the NR1 or
NR2B subunit caused a marked reduction in the calcium tran-
sients. However, inhibition of the expression of the NR2D or
NR3A subunit caused a smaller, but still significant, reduction,
compared with those caused by NR1 or NR2B knockdown. In
both in vitro and in vivo experiments, the smaller effect produced
by the NR3A AS-ODN treatment probably reflects the reduction
in calcium permeability caused by the NR3A in the NMDAR
channel (45, 47). Thus, even if the total number of receptors is
reduced by blockade of the NR3A subunit expression, the cal-
cium influx can be partially compensated by the increased per-
meability of other NMDAR subunits.
The present knockdown experiment showed the role of the
NR1, NR2B, NR2D, and NR3A subunits in the mechanical
hyperalgesia induced by i.pl. PGE2 (Fig. 5). The observation that
NR1 and NR2B depletion caused a decrease in the intensity of
the mechanical hyperalgesia was not surprising, because NR1
subunits are essential for the function of the NMDARs (48), and
the involvement of NR2B in pain processing has been demon-
strated (49). In this context, it has been described that functional
NMDARs are formed only when the NR1 subunit is coexpressed
with the NR2 subunits (50). Of note, the presence of NR3A
subunits has been proposed to decrease the sensitivity of
NMDARs to extracellular Mg2+ (45). This result is in line with
our finding that NMDARs in the satellite cells were not sensitive
to Mg2+ blockade (Fig. 4D), as observed in other glial cells such
as astrocytes (37, 38). Therefore, we suggest that these receptors
can be activated regardless of the negative membrane resting
potential of these cells. In fact, we did find expression of the
NR3A subunit only in satellite cells (Fig. S7), reinforcing this
idea. Together, our in vivo and in vitro experiments using AS-
ODN indicate that NMDARs activated during the PGE2-
induced hyperalgesia are most likely present in glial cells rather
than in neurons.
Conclusion
The present study shows compelling evidence in support of
a glutamatergic-dependent signaling mechanism in the DRG and
proposes a physiological role of DRG NMDARs in the expres-
sion of peripheral inflammatory mechanical hyperalgesia. The
mechanisms by which satellite cells activated by GLU interfere
with the neuronal excitability and thus contribute to the main-
tenance of sensitization to mechanical stimulation remain to be
determined. Importantly, the chemical communication between
neurons and satellite cells in the DRG has been described (51).
In that study, ATP released by neurons was shown to activate
P2X7 receptors in satellite cells in vitro. We may speculate that
such neuron–glia communication might be involved in the cross-
depolarization that is known to affect neurons neighboring
excited neurons in the DRG (52).
The retrograde sensitization of the primary sensory neuron
was proposed as an essential mechanism for induction and
maintenance of peripheral inflammatory hyperalgesia. It was
suggested that this phenomenon was due to the release of GLU
in the spinal cord, which acted retrogradely on NMDARs pres-
ent at the presynaptic terminals of the primary sensory neuron
(15, 17). In the present investigation, we performed a series of
experiments that altogether change this view and suggest that the
retrograde sensitization occurs predominantly in the DRG itself.
This suggestion is supported by the finding that GLU is present
in the cell bodies of the DRG (53). Satellite glial cells are found
wrapping the neuronal somata, isolating the ganglionar cell
bodies. Thus, GLU released by sensory neurons in the DRG
basically activates NMDARs in satellite cells. The mechanism by
which GLU-activated satellite cells influence neuronal excitability
remains to be elucidated. Devor (27) has highlighted several
peculiarities of the DRG, including the finding that it lacks
a blood–nerve barrier. This observation, along with our conclusion
that the communication between glial cells and neurons is a
determinant in the maintenance of mechanical hyperalgesia, opens
the possibility of designing NMDAR antagonists with primarily
peripheral activity.
Materials and Methods
For complete details, see SI Materials and Methods.
Animals. The experiments were performed on male Wistar rats (100 g for in
vitro tests; 180–200 g for behavioral tests).
ODNs. AS-ODNs specific for each NMDAR subunit were used to induce
knockdown of the NR1, NR2A, NR2B, NR2C, NR2D, NR3A, or NR3B subunits in
rat L5-DRG neurons. I.gl. injections were performed for four (Fig. S6) or five
(Fig. 5 and Fig. S5) consecutive days. For the experiment shown in Fig. 5 and
Fig. S5, on the fifth day, after the behavioral tests with PGE2 (100 ng), the
L5-DRGs of the ipsilateral side of PGE2 injection were harvested and pre-
pared for evaluation of the expression of NMDAR subunits by real-time PCR.
Drug Administration. I.t. injections were performed as described (25). The i.gl.
drug administration was carried out in accordance with refs. 24 and 54.
Briefly, rats were anesthetized by inhalation of 2% (vol/vol) isoflurane. The
injecting needle was inserted through the punctured skin, toward the
intervertebral space between L5 and L6, until the tip touched the lateral
region of the vertebrae. To reach the space between the transverse pro-
cesses of the L5 and L6 vertebrae, smooth movements of the needle were
made until the bone resistance was diminished and an ipsilateral paw flinch
reflex was observed.
Mechanical Hyperalgesia Evaluation: Electronic von Frey Test. Mechanical
hyperalgesia was evaluated in rats as reported (55). The test consisted of
evoking a hind-paw flexion reflex in rats, placed in acrylic cages with wire
grid floors, with a hand-held force transducer (electronic anesthesiometer;
IITC Life Science) adapted with a 0.7-mm2 polypropylene tip, which was
applied by the investigator perpendicularly to the central area of the hind
paw with a gradual increase in pressure.
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Primary DRG Cultures. Rats were euthanized by decapitation under anesthesia.
DRGswere collected and processed as described (56). Cells were dissociated and
plated in six-well plastic plates coated with Matrigel (BD). The cultures were
maintained in a humid 5% CO2 atmosphere at 37 °C for 24–36 h.
Intracellular Calcium Images. Calcium influx was used as a parameter to
indicate neuronal activation. Intracellular calcium was monitored by using
the fluorescent calcium indicator Fluo-3 AM (Molecular Probes). Cells were
loaded with 5 μM Fluo-3 AM for 1 h at room temperature, washed three
times, and allowed to de-esterify for ∼15 min in Hank’s buffered saline
solution containing 10 mM Hepes. Fluorescent images were acquired by
using a confocal microscope (Leica SP5) with an Argon laser (488-nm
wavelength for Fluo-3 excitation). All drugs were directly administered
during image acquisition using a micropipette. Data are presented as ΔF/F0
to normalize for differences in cell loading.
Data Analysis. Results are presented as the means ± SEM of groups containing
five animals in the in vivo experiments and of three different experiments in
the in vitro essays. The statistical analysis was performed by using one-way
ANOVA followed by the Bonferroni test. Differences were considered stat-
istically significant at P < 0.05.
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